Breaking News, Collaborations & Alliances

ArQule Receives Wyeth Payment for IND

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

ArQule, Inc. has received a milestone payment from Wyeth in connection with the filing of an Investigational New Drug (IND) application by Wyeth to the FDA related to a compound under development for Alzheimer’s disease. In connection with its former chemistry services business, ArQule has agreements with pharmaceutical collaborators such as Wyeth. Certain of the agreements include provisions for milestone and royalty payments in the event of development and commercialization of drugs derived...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters